ESC Premium Access

The emerging role of novel oral anticoagulants (NOACS) in extended treatment of VTE: what we have learned.

Congress Session

About the speaker

Doctor Jeffrey Weitz

Thrombosis & Atherosclerosis Research Institute (TaARI), Hamilton (Canada)
20 presentations
0 follower

5 more presentations in this session

Opening remarks - Managing patients with pulmonary embolism after hospital discharge... Considering the evidence for anticoagulation.

Speaker: Professor D. Jimenez (Madrid, ES)

Thumbnail

Understanding the risk of recurrence in venous thromboembolism (VTE)... In whom the risk persists.

Speaker: Professor D. Jimenez (Madrid, ES)

Thumbnail

Moving from acute to continued treatment after hospital discharge... Selecting the right anticoagulant at the right dose for the right patient.

Speaker: Professor D. Jimenez (Madrid, ES) Doctor J. Weitz (Hamilton, CA)

Thumbnail

Question and Answers - Managing patients with pulmonary embolism after hospital discharge… Considering the evidence for anticoagulation.

Speaker: Doctor J. Weitz (Hamilton, CA) Professor D. Jimenez (Madrid, ES)

Thumbnail

Closing remarks - Managing patients with pulmonary embolism after hospital discharge... Considering the evidence for anticoagulation.

Speaker: Doctor J. Weitz (Hamilton, CA)

Thumbnail

Access the full session

Managing patients with pulmonary embolism after hospital discharge... Considering the evidence for anticoagulation

Speakers: Doctor J. Weitz, Professor D. Jimenez, Professor D. Jimenez, Professor D. Jimenez, Doctor J. Weitz...
Thumbnail

About the event

Image

ESC CONGRESS 2017

26 August - 30 August 2017

Sessions Presentations

This platform is supported by

logo Novo Nordisk